METHODS OF TREATMENT WITH TASELISIB
- 专利权人:
- Genentech; Inc.
- 发明人:
- Kyle Edgar,Lori Friedman,Deepak Sampath,Kyung Song,Ingrid Wertz,Timothy Wilson
- 申请号:
- US15194859
- 公开号:
- US20160375033A1
- 申请日:
- 2016.06.28
- 申请国别(地区):
- US
- 年份:
- 2016
- 代理人:
- 摘要:
- Taselisib (GDC-0032) induces the degradation of mutant-p110 alpha protein. Methods for selecting patients with mutant PI3K tumors for treatment with taselisib are described.
- 来源网站:
- 中国工程科技知识中心